These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 11741789)

  • 1. Clustered ergot alkaloids modulate cell-mediated cytotoxicity.
    Kren V; Fiserová A; Weignerová L; Stibor I; Halada P; Prikrylová V; Sedmera P; Pospísil M
    Bioorg Med Chem; 2002 Feb; 10(2):415-24. PubMed ID: 11741789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pergolide, terguride and N,N'-spacer-linked oligomers of both interact with 5-HT2A receptors of rat tail artery.
    Kren V; Eich E; Pertz HH
    Physiol Res; 2004; 53(1):35-43. PubMed ID: 14984312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of the partial dopamine receptor agonist, terguride, on the field-stimulated vas deferens in the mouse].
    Carratù MR; De Serio A; Lagioia R; Conte-Camerino D; Ferrari E; Mitolo-Chieppa D
    Boll Soc Ital Biol Sper; 1990 Jan; 66(1):35-42. PubMed ID: 1969741
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ergot alkaloid glycosides with immunomodulatory activities.
    Kren V; Fiserová A; Augé C; Sedmera P; Havlícek V; Síma P
    Bioorg Med Chem; 1996 Jun; 4(6):869-76. PubMed ID: 8818236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of lisuride, terguride and bromocriptine on intraocular pressure (IOP).
    Al-Sereiti MR; Turner P
    Br J Clin Pharmacol; 1989 Feb; 27(2):159-63. PubMed ID: 2713211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro antiplasmodial activities of semisynthetic N,N'-spacer-linked oligomeric ergolines.
    Jenett-Siems K; Köhler I; Kraft C; Pertz HH; Kren V; Fiserová A; Kuzma M; Ulrichová J; Bienzle U; Eich E
    Bioorg Med Chem; 2004 Feb; 12(4):817-24. PubMed ID: 14759742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacologic arrest of lactation. Comparison of Deprenon, lisuride, terguride and mestranol].
    Vido I; Cepický P
    Cesk Gynekol; 1989 Nov; 54(9):654-61. PubMed ID: 2624954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effects of terguride, an ergot alkaloid derivative, on the central nervous system: biochemical and behavioral studies].
    Ikoma Y; Akai T; Nakata Y; Hara K; Wachtel H; Yamaguchi M
    Nihon Yakurigaku Zasshi; 1993 Aug; 102(2):113-29. PubMed ID: 8370555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Terguride, a mixed dopamine agonist-antagonist, in animal models of Parkinson's disease.
    Koller WC; Herbster G
    Neurology; 1987 Apr; 37(4):723-7. PubMed ID: 3561789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetics and pharmacodynamics of terguride following intramuscular administration in cows and goats.
    Lapka R; Krejci P; Lidický J; Frühaufová M; Rezábek K
    Acta Physiol Pol; 1989; 40(1):139-44. PubMed ID: 2603744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Terguride--a new dopamine agonist drug: a comparison of its neuroendocrine and side effect profile with bromocriptine.
    Ciccarelli E; Touzel R; Besser M; Grossman A
    Fertil Steril; 1988 Apr; 49(4):589-94. PubMed ID: 3127243
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suppression of lactation with Terguride.
    Vĕtr M; Krejcí I
    Acta Univ Palacki Olomuc Fac Med; 1988; 119():347-52. PubMed ID: 2977495
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of the partial dopamine receptor agonists SDZ 208-911, SDZ 208-912 and terguride on central monoamine receptors. A behavioral, biochemical and electrophysiological study.
    Svensson K; Ekman A; Piercey MF; Hoffmann WE; Lum JT; Carlsson A
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Sep; 344(3):263-74. PubMed ID: 1683686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of terguride on the dynamics and mean level of vigilance. A controlled electroencephalographic study with elderly subjects].
    Ulrich G; Suchy I
    Arzneimittelforschung; 1987 Mar; 37(3):350-6. PubMed ID: 3593451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The partial dopamine receptor agonist terguride in the MPTP-induced hemiparkinsonian monkey model.
    Brücke T; Bankiewicz K; Harvey-White J; Kopin I
    Eur J Pharmacol; 1988 Apr; 148(3):445-8. PubMed ID: 3260191
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiserotonergic properties of terguride in blood vessels, platelets, and valvular interstitial cells.
    Kekewska A; Görnemann T; Jantschak F; Glusa E; Pertz HH
    J Pharmacol Exp Ther; 2012 Feb; 340(2):369-76. PubMed ID: 22049464
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroimmunomodulation of natural killer (NK) cells by ergot alkaloid derivatives.
    Fiserová A; Kovárů H; Hajduová Z; Mares V; Starec M; Kren V; Flieger M; Pospísil
    Physiol Res; 1997; 46(2):119-25. PubMed ID: 9727503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic treatment of pathological hyperprolactinemia and acromegaly with the new ergot derivative terguride.
    Dallabonzana D; Liuzzi A; Oppizzi G; Cozzi R; Verde G; Chiodini P; Rainer E; Dorow R; Horowski R
    J Clin Endocrinol Metab; 1986 Oct; 63(4):1002-7. PubMed ID: 3745401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ergot alkaloids inhibit 3H-naloxone binding to opiate receptors in the rat striatum and hippocampus.
    Kosar E; Sumová A; Jakoubek B
    Physiol Bohemoslov; 1986; 35(4):334-9. PubMed ID: 3020603
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro selectivity of lisuride and other ergot derivatives for alpha 1- and alpha 2-adrenoceptors.
    McPherson GA
    Eur J Pharmacol; 1984 Jan; 97(1-2):151-5. PubMed ID: 6321208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.